CLINICAL_TRIALS
research
· 2025-09-18
Clinical Trial Update: Methylprednisolone for Moderate to Severe Traumatic Brain Injury [Phase 4]
Summary
Phase 4 clinical trial evaluating methylprednisolone for moderate to severe traumatic brain injury is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhangjiagang First People's Hospital | Conditions: Traumatic Brain Injury | Phase 4 | Status: NOT_YET_RECRUITING